Literature DB >> 19727860

Neurofibromatosis 1 and dental caries.

Vivian Visnapuu1, Kaisu Pienihäkkinen, Sirkku Peltonen, Risto-Pekka Happonen, Juha Peltonen.   

Abstract

A total of 110 patients with neurofibromatosis 1 (NF1) were evaluated for their dental health. Appropriate cohorts from national Finnish databases were used as reference. The results showed that NF1 patients presented lower rate of caries compared to controls in age groups under 35 years. The differences between NF1 patients and the reference population diminished by age. In conclusion, (1) NF1 per se does not predispose to caries; and (2) even if NF1 had an adverse effect on dental health, poor outcome can be counteracted with good personal dental care supported by well organized primary health care. The results of the present study are important to report since a common anecdotal perception is that the rate of caries may be higher in NF1 compared to reference population.

Entities:  

Mesh:

Year:  2009        PMID: 19727860     DOI: 10.1007/s00784-009-0341-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  5 in total

Review 1.  Neurofibromatosis in children: the role of the orthopaedist.

Authors:  A H Crawford; E K Schorry
Journal:  J Am Acad Orthop Surg       Date:  1999 Jul-Aug       Impact factor: 3.020

2.  Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body.

Authors:  T Kuorilehto; M Pöyhönen; R Bloigu; J Heikkinen; K Väänänen; Juha Peltonen
Journal:  Osteoporos Int       Date:  2004-11-16       Impact factor: 4.507

3.  Increased dental caries in people with neurofibromatosis 1.

Authors:  T Tucker; P Birch; D M Savoy; J M Friedman
Journal:  Clin Genet       Date:  2007-12       Impact factor: 4.438

4.  Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings.

Authors:  Reinhard E Friedrich; Manfred Giese; Rainer Schmelzle; Victor-Felix Mautner; Hanna A Scheuer
Journal:  J Craniomaxillofac Surg       Date:  2003-02       Impact factor: 2.078

5.  Periapical cemental dysplasia is common in women with NF1.

Authors:  Vivian Visnapuu; Sirkku Peltonen; Tero Ellilä; Eero Kerosuo; Kalervo Väänänen; Risto-Pekka Happonen; Juha Peltonen
Journal:  Eur J Med Genet       Date:  2007-04-21       Impact factor: 2.708

  5 in total
  6 in total

1.  Oral soft tissue alterations in patients with neurofibromatosis.

Authors:  Eeva-Mari Jouhilahti; Vivian Visnapuu; Tero Soukka; Heikki Aho; Sirkku Peltonen; Risto-Pekka Happonen; Juha Peltonen
Journal:  Clin Oral Investig       Date:  2011-02-08       Impact factor: 3.573

2.  An unusual oral manifestation of type 1 neurofibromatosis: A case report and review of literature.

Authors:  Vandana Shekar; Vishwanath Rangdhol; W John Baliah; Sivasankari Thirunavukarasu
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

3.  Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Anika Reul
Journal:  J Clin Exp Dent       Date:  2018-02-01

4.  Dental Management of Neurofibromatosis Type 1: A Case Report and Literature Review.

Authors:  Fabienne Wotjiuk; Isabelle Hyon; Sylvie Dajean-Trutaud; Zahi Badran; Tony Prud'homme
Journal:  Int J Clin Pediatr Dent       Date:  2019 Nov-Dec

Review 5.  Craniofacial and oral alterations in patients with Neurofibromatosis 1.

Authors:  Vivian Visnapuu; Sirkku Peltonen; Lotta Alivuotila; Risto-Pekka Happonen; Juha Peltonen
Journal:  Orphanet J Rare Dis       Date:  2018-08-09       Impact factor: 4.123

6.  Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study.

Authors:  Eshwar Thota; John Jims Veeravalli; Sai Krishna Manchala; Bhargavi Priya Lakkepuram; Jayasurya Kodapaneni; Yi-Wen Chen; Li-Tzu Wang; Kevin Sheng-Kai Ma
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.